Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,038 | -77,742 | -59,705 | -38,646 | -17,436 |
| Depreciation Amortization | -351 | -2,638 | -2,158 | -1,495 | -803 |
| Accounts payable and accrued liabilities | -1,524 | -3,424 | -3,180 | -3,981 | -2,986 |
| Other Working Capital | -2,657 | 914 | 901 | 379 | -1,535 |
| Other Operating Activity | 2,891 | 9,313 | 7,754 | 7,175 | 4,494 |
| Operating Cash Flow | $-19,679 | $-73,577 | $-56,388 | $-36,568 | $-18,266 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,824 | 70,170 | 51,711 | 39,685 | 28,718 |
| PPE Investments | N/A | 2 | 17 | 15 | -4 |
| Investing Cash Flow | $20,824 | $70,172 | $51,728 | $39,700 | $28,714 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 505 | 113 | 113 | 10 |
| Financing Cash Flow | $N/A | $505 | $113 | $113 | $10 |
| Exchange Rate Effect | 2 | 7 | 8 | 6 | 7 |
| Beginning Cash Position | 37,983 | 40,876 | 40,876 | 40,876 | 40,876 |
| End Cash Position | 39,130 | 37,983 | 36,337 | 44,127 | 51,341 |
| Net Cash Flow | $1,147 | $-2,893 | $-4,539 | $3,251 | $10,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,679 | -73,577 | -56,388 | -36,568 | -18,266 |
| Capital Expenditure | N/A | -29 | -14 | -15 | -4 |
| Free Cash Flow | -19,679 | -73,606 | -56,402 | -36,583 | -18,270 |